Paloma Partners Management CO Compugen LTD Transaction History

Paloma Partners Management CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.57 - $3.33 $105,741 - $224,278	-67,351 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.76 - $4.64 $78,836 - $132,536	-28,564 Reduced 29.78%	67,351 $217,000
Q4 2021 Feb 14, 2022	BUY	$4.09 - $7.16 $246,475 - $431,483	60,263 Added 169.03%	95,915 $412,000
Q3 2021 Nov 15, 2021	BUY	$5.8 - $8.02 $206,781 - $285,929	35,652 New	35,652 $213,000
Q2 2021 Aug 16, 2021	SELL	$6.87 - $9.16 $533,112 - $710,816	-77,600 Closed	0 $0

Q1 2021 May 17, 2021	BUY	$7.67 - $13.77 $437,811 - $786,005	57,081 Added 278.19%	77,600 $666,000
Q4 2020 Feb 16, 2021	BUY	$12.07 - $17.95 $247,664 - $368,316	20,519 New	20,519 $249,000
Q1 2018 May 15, 2018	SELL	$2.5 - $4.45 $105,452 - $187,705	-42,181 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$2.35 - $4.0 $99,125 - $168,724	42,181	42,181 $105,000

13.7M

131K

76K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $146M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

Stay updated on Paloma Partners Management CO with notifications on news.